@conference{94014da0444c4fb795f59c065658748d,
title = "Fifty two-week efficacy and safety results from SPIRIT-P1: A Phase 3 study of ixekizumab in patients with active psoriatic arthritis. 92nd National Congress of the Italian Society of Dermatology Medical, Surgical, Beauty, and Sexually Transmitted Diseases (SIDeMaST), Sorrento, Italy, May 2017.",
author = "Philip Mease and et.al.",
year = "2017",
month = may,
language = "American English",
note = "92nd National Congress of the Italian Society of Dermatology Medical, Surgical, Beauty, and Sexually Transmitted Diseases (SIDeMaST) ; Conference date: 01-05-2017",
}